Trial · NCT07884539
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Phenylalanine Oxidation | 0-360 minutes in the postprandial period | Quantification of whole-body phenylalanine oxidation using 13CO2 enrichment measured in breath samples following ingestion of labeled phenylalanine. |
| Primary | Phenylalanine Retention | 0-360 minutes in the postprandial period | Quantification of whole-body phenylalanine retention calculated as the difference between phenylalanine intake and total exogenous phenylalanine oxidation following ingestion of labeled phenylalanine. |
| Secondary | Incremental area under the curve for total amino acid concentration | 60 minutes pre-prandial to 360 minutes postprandial | Incremental area under the curve for plasma total amino acid concentrations (mmol/L), including: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, alanine, arginine, aspartic acid, cystine, glutamic acid, glycine, proline, serine and tyrosine , measured from repeated blood samples collected throughout 1-hour pre-prandial period and 6-hour postprandial recovery period |
| Secondary | Time-course data for total amino acid concentration | 60 minutes pre-prandial to 360 minutes postprandial | Changes in plasma concentration of total amino acid concentration (μmol/L) including: free leucine, isoleucine, valine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan, arginine, glutamine, glycine, alanine, serine, glutamic acid, aspartic acid, asparagine, tyrosine, cysteine, proline (combined), measured at 18 time points (t = -60, 0, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200, 220, 240, 270, 300, 330, 360 minutes). |
| Secondary | Incremental area under the curve for essential amino acid concentration | 60 minutes pre-prandial to 360 minutes postprandial | Incremental area under the curve (iAUC) for plasma essential amino acid concentration (μmol/L) including free leucine, isoleucine, valine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan (combined), measured across the 1-hour pre-prandial period and 6-hour postprandial period. |
| Secondary | Time-course data for essential amino acid concentration | 60 minutes pre-prandial to 360 minutes postprandial | Changes in plasma concentration of essential amino acid (μmol/L) including: free leucine, isoleucine, valine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan (combined), measured at 18 time points (t = -60, 0, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200, 220, 240, 270, 300, 330, 360 minutes). |
| Secondary | Incremental area under the curve for branched chain amino acid concentration | 60 minutes pre-prandial to 360 minutes postprandial | Incremental area under the curve (iAUC) for plasma branched chain amino acid concentration (μmol/L) including free leucine, isoleucine and valine measured across the 1-hour pre-prandial period and 6-hour postprandial period. |
| Secondary | Time-course data for branched chain amino acid concentration | 60 minutes pre-prandial to 360 minutes postprandial | Changes in plasma concentration of branched chain amino acid (μmol/L) including: free leucine, isoleucine and valine measured at 18 time points (t = -60, 0, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200, 220, 240, 270, 300, 330, 360 minutes). |
| Secondary | Incremental area under the curve for leucine concentration | 60 minutes pre-prandial to 360 minutes postprandial | Incremental area under the curve (iAUC) for plasma leucine concentration (μmol/L) measured across the 1-hour pre-prandial period and 6-hour postprandial period. |
| Secondary | Time-course data for leucine concentration | 60 minutes pre-prandial to 360 minutes postprandial | Changes in plasma concentration of leucine (μmol/L) measured at 18 time points (t = -60, 0, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200, 220, 240, 270, 300, 330, 360 minutes). |
| Secondary | Plasma insulin incremental area under the curve | 60 minutes pre-prandial to 360 minutes postprandial | Incremental area under the curve for plasma insulin concentrations (mmol/L), measured from repeated blood samples collected throughout the 1-hour pre-prandial period and 6-hours postprandial recovery period. |
| Secondary | Time-course data for insulin concentration | 60 minutes pre-prandial to 360 minutes postprandial | Changes in plasma concentration of insulin (pmol/L) measured at 18 time points (t = -60, 0, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200, 220, 240, 270, 300, 330, 360 minutes). |
| Secondary | Plasma glucose incremental area under the curve | 60 minutes pre-prandial to 360 minutes postprandial | Incremental area under the curve for plasma glucose concentrations (mmol/L), measured from repeated blood samples collected throughout the 1-hour pre-prandial period and 6-hours postprandial recovery period. |
| Secondary | Time-course data for glucose concentration | 60 minutes pre-prandial to 360 minutes postprandial | Changes in plasma concentration of glucose (mmol/L) measured at 18 time points (t = -60, 0, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200, 220, 240, 270, 300, 330, 360 minutes). |
| Secondary | Capillary blood β-hydroxybutyrate incremental area under the curve | 60 minutes pre-prandial to 360 minutes postprandial | Incremental area under the curve for capillary blood β-hydroxybutyrate concentrations (mmol/L), measured using capillary blood samples collected throughout the 1-hour pre-prandial period and 6-hours postprandial recovery period. |
| Secondary | Time-course data for capillary β-HB concentrations | 60 minutes pre-prandial to 360 minutes postprandial | Changes in capillary blood β-OHB concentration (mmol/L) measured at 9 time points (t = -60, 0, 30, 60, 120, 180, 240, 300, 360 minutes). |
| Secondary | Whole-body myofibrillar protein breakdown rate | 0-360 minutes in the postprandial period | Quantification of whole-body myofibrillar protein breakdown rate during the 6-hour postprandial recovery period using D3-3MH tracer consumed 18 hours before start of test day. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07884539/registered